University of Pittsburgh PITT HOME  |  FIND PEOPLE  |  CONTACT US  
 
Health Sciences @ Pitt   |    UPMC   |    HSLS   |    School of Medicine   |    Health Sciences Calendar   |    Our News & Events  
 
HOME
ABOUT US
FACULTY
CLINICAL TRAINEES
RESEARCH TRAINEES
ATTENTION ALUMNI
RESIDENCY PROGRAM
RESIDENT WEBSITE
CONFERENCES
EVENTS
CORNEA FELLOWSHIP PROGRAM
GLAUCOMA FELLOWSHIP PROGRAM
NEURO-OPHTHALMOLOGY FELLOWSHIP PROGRAM
ORBITAL, OCULOPLASTICS AND AESTHETIC SURGERY FELLOWSHIP
PEDIATRIC OPHTHALMOLOGY FELLOWSHIP PROGRAM
RETINA FELLOWSHIP PROGRAM
CLINICAL RESOURCES
VISUAL DIAGNOSTICS, IMAGING & LASERS
OPHTHALMOLOGY RESEARCH
RESEARCH LABORATORIES
CORE RESEARCH FACILITIES
GIVING & DEVELOPMENT
LECTURE SCHEDULE
LINKS
EMPLOYMENT OPPORTUNITIES
NEWS & AWARDS
Faculty
divider bar
 
05Friberg.jpg Thomas R. Friberg, MD
Professor of Ophthalmology
Director, Medical and Surgical Retinal Diseases
University of Pittsburgh School of Medicine

Eye & Ear Institute
203 Lothrop Street, Room 825
Pittsburgh, PA 15213
Phone: 412-647-2214
Email: friberg@pitt.edu
Fax: 412-647-5119
Faculty Research Interests
 
bullet point  Education
a dividing bar
University of Minnesota Institute of Technology Minneapolis, MN
1968
Mechanical Engineering
B.S.

Stanford Grad. Sch. of Engineering, Stanford, CA
1969
Fluid mechanics, heat transfer and design
M.S.

University of Minnesota School of Medicine, Minneapolis, MN
1978
Medicine
M.D.
 
bullet point  Academic Affiliation
a dividing bar
1973-1974 Medical Internship, Hennepin County General Hospital, Minneapolis, MN
1974-1977 Ophthalmology Residency: Stanford University Medical Center, Stanford, CA

1978 Retina Fellowship: Massachusetts Eye & Ear Infirmary and Harvard Medical School, Dept. of Ophthalmology
1979 Vitreous Fellowship: Duke Eye Center, Durham, NC

1979-1983 Director of Retina Service, Assistant Professor of Ophthalmology, Medical College of Georgia, Dept. of Ophthalmology, Augusta, GA

1983-1985 Director of Retina Service, Associate Professor of Ophthalmology, University of Texas, Health Science Center - Dallas, Department of Ophthalmology, Dallas, TX

1985-1991 Director of Retina Service, Associate Professor of Ophthalmology, University of Pittsburgh, Eye and Ear Hospital, Pittsburgh, PA
1985-present Staff appointments: University of Pittsburgh Medical Center (formerly Eye and Ear Hospital of Pittsburgh), Veteran's Administration Medical Center
1992-1996 Acting Chairman, Department of Ophthalmology, University of Pittsburgh School of Medicine
1992-present Director of Retina Service, Professor of Ophthalmology, University of Pittsburgh School of Medicine
 
bullet point  Publications
a dividing bar
Friberg TR, Braunstein RA, Bressler NM: "Sudden Visual Loss Associated with Sexual Activity." Current Awareness in Biomedicine. Sheffield, England. Human Sexuality, Vol. 3, No. 15, August 1995.

Friberg TR, Braunstein RA, Bressler NM: "Sudden Visual Loss Associated with Sexual Activity." Ophthalmology Times 1995.

"Bright future for ER: YAG Laser, Vitreoretinal Surgery, Breaking News." Ophthalmology Times, December 18, 1995, p.10.

Friberg TR: "Sudden Loss of Vision" in Diagnostic Challenges, The Courtlandt Forum, pp 160-165, June 25, 1996.

Emergency Medicine: "Sexual Activity and Sudden Blindness." Excerpta Medica, Inc., January 1996, p. 60.

Friberg TR, Zafiropulos V, Kalaitzaki M, Kowalski R, Petrakis J, Fotakis C: Excimer Laser Cleaning of Mold-91. Contaminated Paper: Sterilization and Air Quality Considerations. Lasers in Medical Science. 12:55-59, 1997.

Friberg TR: Age-related macular degeneration. The Cortlandt Forum. 10(7):173-187, July 1997.

Friberg, TR: Management of bleeding during vitreoretinal surgery. Vitreoretinal Surgery and Technology; September 1997.

Friberg TR, Karatza EC: "The treatment of macular disease using a micropulsed and continuous wave 810 nm diode laser." Ophthalmology, 104: 2030-2038, December 1997.

Friberg TR, Zafiropuloz V, Futakis C: Removal of fungi and stains from paper substrates using excimer laser cleaning strategies. Restauratorenbläter, Verlag, Mayer and Co. Vienna, Austria, 1997.

Friberg, TR: Update on Diabetic Retinopathy. The Courtlandt Forum, 11(9): 185-204, 1998.

Richard-James Silicone Oil Study Group: Azen SP, Scott IU, Flynn HW Jr., et al. Silicone oil in the repair of complex retinal detachments. A prospective observational study. Ophthalmology, 105:1587-1597, 1998.

"New Ideas on Lasering Drusen: minimal lesions, longer time frame." Eye Net of the American Academy of Ophthalmology, September 1998, p. 20.

"Low Intensity Laser: An Option for AMB?" Eye Net of the Academy of Ophthalmology, March 1999, pp. 49-50. Friberg TR: Papilledema, optic neuritis, or neither? The Cordlandt Forum, 12(7): 173-174, July 1999.

Friberg TR: Treatment of macular disease with a binocular indirect ophthalmoscope laser delivery system. Ophthalmic Surg & Lasers, 30(7): 518-522, 1999.

Friberg TR and Guibord NM: Corneal endothelial cell loss after multiple vitreoretinal procedures and the use of silicone oil. Ophthalmic Surg & Lasers, 30(7): 528-534, 1999.

The Age-Related Eye Disease Study Research Group: The age-related eye disease study (AREDS): Design Implications AREDS Report No. 1. Controlled Clinical Trials, 20:573-600, 1999.

Friberg TR: Editorial: Subthreshold (invisible) modified grid diode laser photocoagulation and diffuse diabetic macular edema (DDME). Ophthalmic Surgery & Lasers, 30(9):705, November/December 1999.

Friberg TR: The prophylactic treatment of age-related macular degeneration (PTAMD) clinical trial. The IRIS Medical Newsletter, 4(1): pp. 3-4, 1999.
 
bullet point  Grants
a dividing bar
    1. 1990-2000 Age-Related Eye Disease Study (AREDS). National Eye Institute, Principal Investigator, $ 3,181,516 total cost-to-date (contract).

    2. 1995-1998 Prophylactic Diode Laser Photocoagulation for the Prevention of Choroidal Neovascularization in Age-Related Macular Degeneration, Eye and Ear Foundation of Pittsburgh, Principal Investigator, $150,000 total cost

    3. 3/99-2/00 A Phase III randomized, multi-center, double-masked, placebo controlled parallel group study with Tin Ethyl Etiopurpurin photodynamic therapy in the treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Miravant Medical Technologies, Principal Investigator, $90,175 total cost.

    4. 1/00-12/00 A Randomized, Controlled Study on the Efficacy and Safety of Sandostatin LAR in the Therapy of Patients with Moderately Severe or Severe Non-proliferative Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR). Novartis Pharmaceuticals Corp., Principal Investigator, $73,508 total cost.
 
 
  Top of page  |  Home  |  Contact Us Last Update 10/20/2014  
  © Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.